Human herpesvirus-6 (HHV-6) isolation and products
AssigneeThe United States of America as represented by the Department of Health and Human Services
InventorsSyed Zaki Salahuddin, Dharam V Ablashi, Steven F. Josephs, Carl W. Saxinger, Flossie Wong-Staal, Robert C. Gallo
Life of this patent
Estimating the term…
Abstract
A new human B lymphotropic virus, also designated human herpesvirus-6, has been isolated. DNA, molecular clones, antigenic viral proteins and antibodies having specificity to the new virus have been prepared. Various utilities of the new virus and products derived therefrom have been described.
Claims3
An isolated polypeptide encoded by a first nucleic acid which hybridizes under stringent conditions to a second nucleic acid from an isolated human herpes virus having the morphology of a human herpes virus and a double-stranded DNA genome of about 170 Kb, wherein genomic DNA from said isolated human herpes virus hybridizes under stringent conditions with nucleic acid of molecular clone ZVH14 (ATCC Accession No. 40,247);
- and further wherein said first nucleic acid does not hybridize under said stringent conditions with the nucleic acid of:
- (a) Epstein-Barr virus;
- (b) human cytomegalovirus (CMV);
- (c) Herpes Simplex virus (HSV);
- (d) Varicella-Zoster virus (VZV);
- or
- (e) Herpes virus saimiri.
A composition comprising antigenic protein of an isolated human herpes virus having the morphology of a human herpes virus and a double-stranded DNA genome of about 170 Kb, wherein genomic DNA from said isolated human herpes virus hybridizes under stringent conditions with nucleic acid of molecular clone ZVH14 (ATCC Accession No. 40,247);
- and further wherein said first nucleic acid does not hybridize under said stringent conditions with the nucleic acid of:
- (a) Epstein-Barr virus;
- (b) human cytomegalovirus (CMV);
- (c) Herpes Simplex virus (HSV);
- (d) Varicella-Zoster virus (VZV);
- or
- (e) Herpes virus saimiri.
Dependencies are inferred from the claim text.